Mode
Text Size
Log in / Sign up

Calcium signaling dysregulation drives keratinocyte defects and immune activation in psoriasisCalcium signaling problems may drive the cycle of psoriasis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider calcium signaling dysregulation as a mechanistic contributor to psoriasis, though clinical validation is lacking.

This systematic review examines the mechanistic roles of calcium (Ca2+) signaling and store-operated calcium entry (SOCE) dysregulation in psoriasis. The authors synthesize evidence from cellular and molecular studies, focusing on two compartments: keratinocytes and immune effector cells.

In keratinocytes, impaired Ca2+ sensing and SOCE dysfunction lead to insufficient local Ca2+ signaling and defective differentiation, compromising skin barrier homeostasis. In the immune compartment, persistently activated Ca2+-dependent signaling promotes Th17 polarization and IL-17A release via the Calcineurin–NFAT–RORγt pathway.

The review proposes a theoretical model of 'compartment-specific bidirectional calcium dysregulation' as a potential target for precision immunomodulation. However, the authors note this model has not been clinically validated, and the evidence is based on association rather than clinical trial results. Limitations were not reported in the source.

Practice relevance is currently limited to mechanistic understanding; no direct clinical recommendations can be drawn. The findings may inform future therapeutic strategies targeting calcium signaling pathways in psoriasis.

How this fits prior evidence

This systematic review extends prior coverage of psoriasis pathogenesis by proposing a mechanistic model linking calcium signaling dysregulation to both keratinocyte dysfunction and immune activation. It contrasts with prior findings on lifestyle factors (smoking, alcohol, weight loss) and therapeutic considerations (biologics, lipid monitoring) by focusing on a fundamental signaling pathway rather than clinical interventions or comorbidities. The review addresses a gap in understanding the molecular basis of psoriasis, complementing earlier work on environmental triggers and treatment effects.

Living with psoriasis means dealing with more than just itchy, red patches. It involves a complex cycle where the skin's outer layer fails to protect itself while the immune system stays in a state of high alert. Researchers have identified a specific mechanism at the heart of this problem: calcium signaling.

In the skin cells (keratinocytes), faulty calcium sensing prevents them from maturing and building a strong barrier. Meanwhile, in the immune compartment, calcium-dependent signals stay active too long. This constant activity pushes the body toward Th17 polarization and the release of IL-17A, a protein that fuels inflammation. Essentially, both sides of the skin's defense are malfunctioning at once.

While these findings offer a clear map of how psoriasis works at a cellular level, it is important to note that this research focuses on biological mechanisms rather than clinical trials. The theory of using these specific calcium pathways as targets for treatment has not been tested in patients yet. It provides a roadmap for future precision medicine but does not replace current treatments.

What this means for you:
Faulty calcium signaling in both skin cells and immune cells may drive the inflammation seen in psoriasis.

Common questions

What role does calcium play in psoriasis?

Calcium acts as a messenger in your body. In people with psoriasis, the way these cells sense and use calcium is broken. In skin cells, it leads to poor development of the skin barrier. In immune cells, it causes them to stay active, leading to more inflammation.

How does this affect the skin's outer layer?

When skin cells (keratinocytes) cannot sense calcium properly, they fail to differentiate correctly. This means the skin cannot build a healthy barrier, which is a key part of how psoriasis affects the body's surface.

Is this a new treatment for psoriasis?

No, this research identifies a biological mechanism rather than a new drug. It highlights specific pathways that could be targeted in the future, but these methods have not been clinically validated in patients yet.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Psoriasis is a chronic inflammatory skin disease driven by the synergistic interplay between aberrant epidermal proliferation and immune imbalance, with its core pathological process centered on the IL-23/IL-17 inflammatory axis. In recent years, accumulating evidence has demonstrated that calcium (Ca2+) signaling not only participates in keratinocyte (KC) differentiation and the maintenance of skin barrier homeostasis but also serves as a critical upstream regulator of the maturation and activation of immune cells, including dendritic cells (DCs), Th17 cells, neutrophils, and mast cells. This review systematically summarizes the mechanistic roles of Ca2+ signaling dysregulation in psoriatic keratinocytes and multiple immune effector cells, with particular emphasis on the regulatory functions of SOCE within the DC–Th17 inflammatory axis. Current evidence indicates that the collapse of epidermal structural support systems, impaired Ca2+ sensing, and SOCE dysfunction collectively contribute to insufficient local Ca2+ signaling and defective KC differentiation. In contrast, persistently activated Ca2+-dependent signaling within the immune compartment promotes Th17 polarization, IL-17A release, and inflammatory cascade amplification through downstream pathways including Calcineurin–NFAT–RORγt. Based on these observations, this review further proposes that “compartment-specific bidirectional calcium dysregulation” may represent an underrecognized pathological pattern in psoriasis, characterized by the coexistence of impaired epidermal calcium signaling and persistent immune calcium hyperactivation. Furthermore, this review discusses therapeutic strategies targeting Ca2+ signaling and their translational challenges, including SOCE-targeted interventions and future combinatorial therapeutic approaches. Overall, this review reappraises the pathogenesis of psoriasis from the perspective of Ca2+ signaling with the aim of providing a novel theoretical basis for future precision immunomodulation and the development of innovative therapeutic strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.